Kiran Mazumdar-Shaw

Syngene appoints Jonathan Hunt as CEO-designate

Read more

Biocon posts Rs 306 cr net profit in Q2FY16

Read more

Syngene International IPO oversubscribed 31 times

Read more

Kiran Mazumdar-Shaw in Scientific American’s 100 Biotech visionaries list

Read more

Kiran Mazumdar Shaw ranked No. 2 in Global ‘Medicine Maker Power List’ 2015

Read more

Kiran Mazumdar-Shaw ranked No. 2 in Global ‘Medicine Maker Power List’ 2015

Read more

Biocon top line grows 15 per cent in Q4 FY15

Read more

Syngene seeks approval for IPO, files DRHP

Read more

Biocon recognised for outstanding contribution to public health by WHO – India

Read more

Kiran Mazumdar-Shaw honoured by Federation University Australia

Read more